The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于2026年第21周流感住院率？
2026年第21周流感住院率？
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$5,474 交易量
$5,474 交易量
2026-06-05
<80
否
80–85
否
85–90
是
90–95
否
95–100
否
100以上
否
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$5,474 交易量
$5,474 交易量
2026-06-05
<80
$647 交易量
否
80–85
$360 交易量
否
85–90
$1,193 交易量
是
90–95
$1,382 交易量
否
95–100
$928 交易量
否
100以上
$964 交易量
否
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
市场开放时间： Jun 1, 2026, 12:42 PM ET
交易量
$5,474结束日期
2026-06-05市场开放时间
Jun 1, 2026, 12:42 PM ET已提议结果: 否
无争议
最终结果: 否
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
交易量
$5,474结束日期
2026-06-05市场开放时间
Jun 1, 2026, 12:42 PM ET已提议结果: 否
无争议
最终结果: 否
The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题